ResMed (RMD) Tops Q4 EPS by 3c, Revenue Beats
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $226.75 --0%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $453.1 million versus the consensus estimate of $436.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
- Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
